A Study to Learn About the Study Medicine PF-07293893 at Different Dose Levels in Healthy Adult Participants
A Phase 1, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled, 4-Period, Crossover, First-in-Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Ascending Oral Doses of PF-07293893 Administered to Healthy Adult Participants
Category & Conditions: Cardiovasular Diseases and Conditions
Medicine: PF-07293893
ClinicalTrials.gov Identifier (NCT): NCT05907395
Protocol ID: C5171001
Open Plain Language Summary Result:
Click here